FindTrial
Sign In

The clinical outcome of MPA in Primed-progesterone ovarian stimulation protocol for advanced endometriosis patients undergoing IVF cycle

The clinical outcome of MPA in Primed-progesterone ovarian stimulation protocol for advanced endometriosis patients undergoing IVF cycle

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-15007399
Enrollment
Unknown
Registered
2015-11-16
Start date
1990-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

advanced endometriosis patients:HMG+MPA in follicular phase in advanced endometriosis patients
tubal infertility patients group:HMG+MPA in follicular phase in tubal infertility patients

Sponsors

The Shanghai Ninth People's Hospital affiliated of Shanghai JiaoTong University of medical school
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 20-40y, regular ovulation, FSH less than 10IU/L and AFC 5-20.

Exclusion criteria

Exclusion criteria: ovarian failure, pcos, acute genital tract infection and other systemtic diseases.

Design outcomes

Primary

MeasureTime frame
oocyte retrieval rate;maturation rate;fertilization rate;implantation rate;—

Secondary

MeasureTime frame
viable embryo rate;incidence of premature OHSS;cleavage rate;clinical pregnancy rate;—

Countries

China

Contacts

Public ContactYanping Kuang
kuangyanp@126.com+86 021-53078080

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026